Unproven for older women, digital mammography saps Medicare dollars

By Joe Eaton, Elizabeth Lucas and David Donald

High-tech, digital mammography may not be any better at detecting breast cancer in women over 65 than older film-based systems, but Medicare

Brain cancer trial may influence science on toxic chemical

By Jim Morris

A McCullom Lake, Ill., plant, operated by Rohm and Haas, a subsidiary of Dow Chemical Co., is at the root of a potentially groundbreaking la

Data analysis on digital mammography Medicare claims

By David Donald and Elizabeth Lucas

The Center analyzed Medicare claims data obtained from the Centers for Medicare and Medicaid Services (CMS). For the digital mammography ana
Advertisement

Forty percent of Medicare spending on common cancer screenings unnecessary, probe suggests

By Rochelle Sharpe and Elizabeth Lucas

Forty percent of Medicare spending on common cancer screenings may be unnecessary

Research methodology

By David Donald and Elizabeth Lucas

A look at how data was gathered for Medicare reporting

Digital mammography no better than film for most women, despite increased costs

By Joe Eaton

New report shows little difference despite increased costs for digital
Advertisement

Landmark diesel exhaust study stalled amid industry and congressional objections

By Jim Morris

Publication of a landmark government study of lung cancer in miners is delayed by an industry group and its congressional allies

2 plead guilty in Miss. chemotherapy fraud case

By The Associated Press

Doctor, billing agent plead guilty to charges related to diluted chemotherapy case in Miss.

U.S. asbestos imports condemned by health experts, activists

By Jim Morris

More than 50 countries have banned asbestos, a toxic mineral linked to cancer and other diseases. The United States isn't one of them.